相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of 53BP1 Is a Gain for BRCA1 Mutant Cells
Elizabeth M. Kass et al.
CANCER CELL (2010)
Inactivation of DNA-Dependent Protein Kinase Leads to Spindle Disruption and Mitotic Catastrophe with Attenuated Checkpoint Protein 2 Phosphorylation in Response to DNA Damage
Zeng-Fu Shang et al.
CANCER RESEARCH (2010)
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Samuel F. Bunting et al.
CELL (2010)
Mechanisms of Drug-Induced Mitotic Catastrophe in Cancer Cells
Jose Portugal et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
Adele Adamo et al.
MOLECULAR CELL (2010)
DNA REPAIR Decision at the break point
Simon J. Boulton
NATURE (2010)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway
Paul Pace et al.
SCIENCE (2010)
Role of senescence and mitotic catastrophe in cancer therapy
Richa Singh et al.
CELL DIVISION (2010)
Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells
Benjamin Thierry et al.
ADVANCED MATERIALS (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Life and death partners: apoptosis, autophagy and the cross-talk between them
A. Eisenberg-Lerner et al.
CELL DEATH AND DIFFERENTIATION (2009)
PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
Cathy Zhang et al.
CLINICAL CANCER RESEARCH (2009)
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
H. Christian Reinhardt et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Targeting the DNA damage response for cancer therapy
Simon N. Powell et al.
DNA REPAIR (2009)
Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
Tina M. Thornton et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2009)
Validation of the Royal Marsden Hospital Prognostic Index in Advanced Esophagogastric Cancer Using Individual Patient Data From the REAL 2 Study
Ian Chau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination
Isabelle Robert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
p38 Mitogen-Activated Protein Kinase- and HuR-Dependent Stabilization of p21Cip1 mRNA Mediates the G1/S Checkpoint
Vanesa Lafarga et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy
Yingmei Wang et al.
MOLECULAR CANCER (2009)
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
Leslie A. Parsels et al.
MOLECULAR CANCER THERAPEUTICS (2009)
APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy
Fares Al-Ejeh et al.
PLOS ONE (2009)
Backup pathways of NHEJ in cells of higher eukaryotes: Cell cycle dependence
George Iliakis
RADIOTHERAPY AND ONCOLOGY (2009)
ATR and Chk1 Suppress a Caspase-3-Dependent Apoptotic Response Following DNA Replication Stress
Katie Myers et al.
PLOS GENETICS (2009)
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Mark S. Cragg et al.
NATURE REVIEWS CANCER (2009)
DNA repair proteins as molecular targets for cancer therapeutics
Mark R. Kelley et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway
Marc Audebert et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Targeting phosphoinositide 3-kinase - Moving towards therapy
Romina Marone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
N. Bucher et al.
BRITISH JOURNAL OF CANCER (2008)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Apoptosis and non-apoptotic deaths in cancer development and treatment response
Elza C. de Bruin et al.
CANCER TREATMENT REVIEWS (2008)
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3
Samuel Sidi et al.
CELL (2008)
Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45
R. Rodriguez et al.
CELL DEATH AND DIFFERENTIATION (2008)
Death through a tragedy: mitotic catastrophe
H. Vakifahmetoglu et al.
CELL DEATH AND DIFFERENTIATION (2008)
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia
Elaine Willmore et al.
CLINICAL CANCER RESEARCH (2008)
DNA damage detection and repair pathways - Recent advances with inhibitors of checkpoint kinases in cancer therapy
Susan Ashwell et al.
CLINICAL CANCER RESEARCH (2008)
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin
Bastiaan Evers et al.
CLINICAL CANCER RESEARCH (2008)
p53: A guide to apoptosis
Erik Meulmeester et al.
CURRENT CANCER DRUG TARGETS (2008)
DNA damage repair and response proteins as targets for cancer therapy
Howard B. Lieberman
CURRENT MEDICINAL CHEMISTRY (2008)
Targeted therapy for cancer using PARP inhibitors
Christopher J. Lord et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Repair of radiation induced DNA double strand breaks by backup NHEJ is enhanced in G2
Wenqi Wu et al.
DNA REPAIR (2008)
Cleavage-mediated activation of Chk1 during apoptosis
Kenkyo Matsuura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
Alessandra Blasina et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Outlook - What drives success for specialty pharmaceuticals?
Mark Gudiksen et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Regulation of DNA repair throughout the cell cycle
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
DNA damage induces two distinct modes of cell death in ovarian carcinomas
H. Vakifahmetoglu et al.
CELL DEATH AND DIFFERENTIATION (2008)
Regulation of DNA double-strand break repair pathway choice
Meena Shrivastav et al.
CELL RESEARCH (2008)
The DNA damage response: Ten years after
J. Wade Harper et al.
MOLECULAR CELL (2007)
Targeted cancer therapies based on the inhibition of DNA strand break repair
M. J. O'Connor et al.
ONCOGENE (2007)
BH3 mimetics to improve cancer therapy; mechanisms and examples
Lin Zhang et al.
DRUG RESISTANCE UPDATES (2007)
Targeting poly(ADP-ribose) polymerase: A two-armed strategy for cancer therapy
Elizabeth Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2007)
RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors
Richard W. Martin et al.
CANCER RESEARCH (2007)
19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl β-D-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse
Li Liu et al.
FASEB JOURNAL (2007)
Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer
Marina Kartachova et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Monitoring of chemotherapy-induced cell death in melanoma tumors by N,N′-didansyl-L-cystine
Avi Cohen et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2007)
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation
Brett Ewald et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
H. Christian Reinhardt et al.
CANCER CELL (2007)
Checkpoint kinase 1 is cleaved in a caspase-dependent pathway during genotoxic stress-induced apoptosis
Naoyuki Okita et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy
Subbareddy Maddika et al.
DRUG RESISTANCE UPDATES (2007)
CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo
Archie N. Tse et al.
CLINICAL CANCER RESEARCH (2007)
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo
David J. Matthews et al.
CELL CYCLE (2007)
Current development of clinical inhibitors of poly (ADP-ribose) polymerase in oncology
Kapila Ratnam et al.
CLINICAL CANCER RESEARCH (2007)
The inhibitors of apoptosis (IAPs) as cancer targets
Allison M. Hunter et al.
APOPTOSIS (2007)
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling
Thomas Stiff et al.
EMBO JOURNAL (2006)
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Minli Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
DNA repair pathways in clinical practice: Lessons from pediatric cancer susceptibility syndromes
Richard D. Kennedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma
K. C. Goldsmith et al.
ONCOGENE (2006)
BCL2 family in DNA damage and cell cycle control
S. Zinkel et al.
CELL DEATH AND DIFFERENTIATION (2006)
BCL-2 in the crosshairs: tipping the balance of life and death
L. D. Walensky
CELL DEATH AND DIFFERENTIATION (2006)
Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities
J. C. Reed
CELL DEATH AND DIFFERENTIATION (2006)
Inhibition of poly(ADP-ribose) pollyrnerase in cancer
Elizabeth Ruth Plummer
CURRENT OPINION IN PHARMACOLOGY (2006)
Targeting the double-strand DNA break repair pathway as a therapeutic strategy
Christopher J. Lord et al.
CLINICAL CANCER RESEARCH (2006)
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
V. Labi et al.
CELL DEATH AND DIFFERENTIATION (2006)
p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1
B. Frazier Taylor et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms
John C. Reed
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
Yan Zhao et al.
CANCER RESEARCH (2006)
Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage
EM Bahassi et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage
CM Sturgeon et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Radiosensitization by the poly(ADP=ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA syntheses
G Noël et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress
R Rodriguez et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair
HE Bryant et al.
NUCLEIC ACIDS RESEARCH (2006)
New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors
Melissa S. Bentle et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
A Jazayeri et al.
NATURE CELL BIOLOGY (2006)
Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated
IG Cowell et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach
IR Hardcastle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2
CM Aliouat-Denis et al.
MOLECULAR CANCER RESEARCH (2005)
Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy
JF Haince et al.
TRENDS IN MOLECULAR MEDICINE (2005)
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-Ribose) polymerase
N McCabe et al.
CANCER BIOLOGY & THERAPY (2005)
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig et al.
NATURE (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine
MA Morgan et al.
CANCER RESEARCH (2005)
Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition
E Gallmeier et al.
CANCER BIOLOGY & THERAPY (2005)
DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs
ET Shinohara et al.
CANCER RESEARCH (2005)
DNA ligase III as a candidate component of backup pathways of nonhomologous end joining
HC Wang et al.
CANCER RESEARCH (2005)
Recent advances in understanding the cell death pathways activated by anticancer therapy
R Kim
CANCER (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers
RS Roberson et al.
CANCER RESEARCH (2005)
Evidence that DNA damage detection machinery participates in DNA repair
CE Helt et al.
CELL CYCLE (2005)
Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland
EL Denchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Selective benzopyranone and pyrimido[2,1-α]isoquinolin-4-one inhibitors of DNA-dependent protein kinase:: Synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro
RJ Griffin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Chk1 is essential for tumor cell viability following activation of the replication checkpoint
SH Cho et al.
CELL CYCLE (2005)
Targeting the checkpoint kinases: Chemosensitization versus chemoprotection
BBS Zhou et al.
NATURE REVIEWS CANCER (2004)
In vivo imaging of β-galactosidase activity using far red fluorescent switch
CH Tung et al.
CANCER RESEARCH (2004)
Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells
NJ Curtin et al.
CLINICAL CANCER RESEARCH (2004)
SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization
IH Ismail et al.
ONCOGENE (2004)
Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361
CR Calabrese et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair
SJ Veuger et al.
ONCOGENE (2004)
Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
M Audebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries
JJJ Leahy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2
M Urist et al.
GENES & DEVELOPMENT (2004)
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
E Willmore et al.
BLOOD (2004)
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
A Sancar et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation
YL Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Apoptosis genes and resistance to cancer therapy - What do the experimental and clinical data tell us?
M Brown et al.
CANCER BIOLOGY & THERAPY (2003)
Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation
M Gatei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Tumor senescence as a determinant of drug response in vivo
IB Roninson
DRUG RESISTANCE UPDATES (2002)
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt et al.
CELL (2002)
DNA and its associated processes as targets for cancer therapy
LH Hurley
NATURE REVIEWS CANCER (2002)
If not apoptosis, then what? - Treatment-induced senescence and mitotic catastrophe in tumor cells
IB Roninson et al.
DRUG RESISTANCE UPDATES (2001)
How nucleotide excision repair protects against cancer
EC Friedberg
NATURE REVIEWS CANCER (2001)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents
M Mahyar-Roemer et al.
ONCOGENE (2001)
Apoptosis: mediator or mode of cell killing by anticancer agents?
JM Brown et al.
DRUG RESISTANCE UPDATES (2001)
DNA double-strand breaks: signaling, repair and the cancer connection
KK Khanna et al.
NATURE GENETICS (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage
R Agami et al.
CELL (2000)
Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice
A de Klein et al.
CURRENT BIOLOGY (2000)
Radiation-induced centrosome overduplication and multiple mitotic spindles in human tumor cells
N Sato et al.
EXPERIMENTAL CELL RESEARCH (2000)
Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
M Ljungman
NEOPLASIA (2000)
分享论文
